MED in UVB Devices in the Presence and Absence of UV Filter
Withdrawn before enrolling · Not applicable
Conditions studied: Healthy Participants and/or Patients
In brief
Psoriasis affects 2-3% of the American population. While a wide variety of therapies currently exist, including topical corticosteroids and Vit D analogs, oral immunosuppressant and retinoid agents a better understanding of phototherapy is needed. Given the prevalence of localized psoriasis and dissatisfaction with treatment, investigation of localized treatment should be a priority for researchers with goals to improve the current standard of care.
Key facts
- Study ID
- NCT03049319
- Run by
- Wake Forest University Health Sciences
- People needed
- 0
- Starts
- 2017-02-01
- Expected to finish
- 2019-01-17
- Last updated by the study team
- 2019-08-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male and female subjects older than 18 years of age.
- Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator.
- Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed.
- The subject is able to complete the study and comply with study instructions, including attending all study visits.
- If a female subject of childbearing potential, subject has a negative urine pregnancy test.
You may not qualify if…
- Subject has a history of being non-responsive to UVB therapy
- Subject received phototherapy in the past four weeks
- Subject used topical therapy within two weeks from baseline (Excluding emollients)
- Subject has used experimental drugs or devices at least one month prior to Baseline
- Subject has a known history of Photosensitivity disorder (Including Xeroderma pigmentosum, SLE, Cockayne Syndrome, Bloom Syndrome) or is currently taking any medication that causes photosensitivity that requires they avoid sunlight.
- Subject has other serious skin disorder or any chronic medical condition that is not well controlled.
- Subject has major illness within 30 days prior to the Baseline visit.
- Subject has history of any immunocompromising disease.
- Subject is pregnant or nursing. Pregnant and nursing females will not be allowed in the study, and females of childbearing potential will have a pregnancy test at Baseline.
- Subject has a skin condition or disease that may require concurrent therapy or may confound the evaluation.
- Presence of any skin condition or coloration that would interfere with placement of test sites or the response or assessment of MED.
Where it is running
- Elias Oussedik — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.